Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Yeda patents IFN-alpha/beta receptor-neutralizing antibodies

Feb. 3, 1998

Phase III results reported for Prosorba

Jan. 30, 1998

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Jan. 27, 1998

Boston Life Sciences to seek U.S. approval for Therafectin

Jan. 23, 1998

Inhibitors of prostaglandin biosynthesis prepared at Abbott

Jan. 23, 1998

Connetics amends payment terms, sells Canadian rights to Ridaura

Jan. 22, 1998

Inhibitors of COX-1/COX-2 from Roche

Jan. 22, 1998

Hydroxamic acid-based inhibitors of TNF and/or MMPs under study at Zeneca

Jan. 22, 1998

Innovative Therapies for Rheumatoid Arthritis

Jan. 22, 1998

Preclinical efficacy results reported for Maruho's NSAID

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...